References
- de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–11. Epub 2016/ 06/28.
- Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2020. Epub 2020/ 10/08. DOI:https://doi.org/10.1038/s41579-020-00459-7
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. Epub 2020/ 01/25.
- Muller O, Neuhann F, Razum O. Epidemiology and control of COVID-19. Dtsch Med Wochenschr. 2020;145:670–674. Epub 2020/ 04/29.
- John Hopkins University. Covid-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020 [cited 2020 Dec 10]. Avaiable from: https://publichealthupdate.com/jhu/
- Ruan S. Likelihood of survival of coronavirus disease 2019. Lancet Infect Dis. 2020;20:630–631. Epub 2020/ 04/03.
- Muller O, Lu G, Jahn A, et al. COVID-19 control: can Germany learn from China? Int J Health Policy Manag. 2020. Epub 2020/ 07/03. DOI:https://doi.org/10.34172/ijhpm.2020.78
- Petersen E, Koopmans M, Go U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20:e238–e44. Epub 2020/ 07/07.
- Streeck H, Schulte B, Kummerer BM, et al. Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany. Nat Commun. 2020;11:5829. Epub 2020/ 11/19.
- Kampf G, Lemmen S, Suchomel M. Ct values and infectivity of SARS-CoV-2 on surfaces. Lancet Infect Dis. 2020. Epub 2020/ 11/23. DOI:https://doi.org/10.1016/S1473-3099(20)30883-5
- Lee EC, Wada NI, Grabowski MK, et al. The engines of SARS-CoV-2 spread. Science. 2020;370:406–407. Epub 2020/ 10/24.
- von Seidlein L, Alabaster G, Deen J, et al. Crowding has consequences: prevention and management of COVID-19 in informal urban settlements. Build Environ. 2020;107472. Epub 2020/ 12/01. DOI:https://doi.org/10.1016/j.buildenv.2020.107472
- Bauch CT. Estimating the COVID-19 R number: a bargain with the devil? Lancet Infect Dis. 2020. DOI:https://doi.org/10.1016/S1473-3099(20)30840-9
- Rannan-Eliya RP, Wijemunige N, Gunawardana J, et al. Increased intensity of PCR testing reduced COVID-19 transmission within countries during the first pandemic wave. Health Aff (Millwood). 2020;101377hlthaff202001409. Epub 2020/ 12/03. DOI:https://doi.org/10.1377/hlthaff.2020.01409
- WHO. Coronavirus Disease (Covid-19). Weekly Epidemiological Update; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
- Kupferschmidt K. Europe is locking down again-but its strategy is unclear. Science. 2020;370:644–645. Epub 2020/ 11/07.
- Alwan NA, Burgess RA, Ashworth S, et al. Scientific consensus on the COVID-19 pandemic: we need to act now. Lancet. 2020;396:e71–e72. Epub 2020/ 10/19.
- Kummitha RKR. Smart technologies for fighting pandemics: the techno- and human- driven approaches in controlling the virus transmission. Gov Inf Q. 2020;37:101481. Epub 2020/ 04/22.
- Li Z, Chen Q, Feng L, et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020;396:63–70. Epub 2020/ 06/09.
- Han E, Tan MMJ, Turk E, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–1534.
- Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020;27. DOI:https://doi.org/10.1093/jtm/taaa039
- Summers J, Cheng HY, Lin H, et al. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health-Western Pacific. 2020;4:100044.
- Habib H. Has Sweden’s controversial covid-19 strategy been successful?. BMJ. 2020;369:m2376. Epub 2020/ 06/14.
- Walker PGT, Whittaker C, Watson OJ, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 2020;369:413–422. Epub 2020/ 06/14.
- Cyranoski D. What China’s coronavirus response can teach the rest of the world. Nature. 2020;579:479–480. Epub 2020/ 03/24.
- Lin H, Guo C, Hu Y, et al. COVID-19 control strategies in Taizhou city, China. Bull World Health Organ. 2020;98:632–637. Epub 2020/ 10/06.
- Liu W, Yue XG, Tchounwou PB. Response to the COVID-19 epidemic: the Chinese experience and implications for other countries. Int J Environ Res Public Health. 2020;17. DOI:https://doi.org/10.3390/ijerph17072304
- Zhang S, Wang Z, Chang R, et al. COVID-19 containment: China provides important lessons for global response. Front Med. 2020;14:215–219. Epub 2020/ 03/27.
- Li CH, Tan CX, Wu AH, et al. COVID-19: the role of community in China’s response. J R Soc Med. 2020;113:280–281.
- Wu J, Wang J, Nicholas S, et al. Application of Big Data Technology for COVID-19 prevention and control in China: lessons and recommendations. J Med Internet Res. 2020;22:e21980.
- Zanin M, Xiao C, Liang T, et al. The public health response to the COVID-19 outbreak in mainland China: a narrative review. J Thorac Dis. 2020;12:4434–4449.
- Zou H, Shu Y, Feng T. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19. Infect Dis Poverty. 2020;9:89.
- Ning Y, Ren R, Nkengurutse G. China’s model to combat the COVID-19 epidemic: a public health emergency governance approach. Glob Health Res Policy. 2020;5:34.
- Zhang J, Zhang R. COVID-19 in China: power, transparency and governance in public health crisis. Healthcare (Basel). 2020;8. DOI:https://doi.org/10.3390/healthcare8030288
- Chen S, Zhang Z, Yang J, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet. 2020;395:1305–1314.
- Lu Q, Cai Z, Chen B, et al. Social policy responses to the Covid-19 crisis in China in 2020. Int J Environ Res Public Health. 2020;17:5896.
- Cao S, Gan Y, Wang C, et al. Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nat Commun. 2020;11:5917.
- Normile D. As normalcy returns, can China keep COVID-19 at bay?. Science. 2020;368:18–19.
- Xing Y, Wong GWK, Ni W, et al. Rapid response to an outbreak in Qingdao, China. N Engl J Med. 2020;383:e129.
- China is testing millions of people in Xinjiang for Covid-19 after one asymptomatic case found. [cited 2021 Jan 06]. Available from: https://edition.cnn.com/2020/10/26/asia/xinjiang-kashgar-coronavirus-intl-hnk/index.html
- Lam HY, Lam TS, Wong CH, et al. The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong-January to May 2020. Int J Infect Dis. 2020;98:51–58.
- Wong MCS, Ng RWY, Chong KC, et al. Stringent containment measures without complete city lockdown to achieve low incidence and mortality across two waves of COVID-19 in Hong Kong. BMJ Glob Health. 2020;5. DOI:https://doi.org/10.1136/bmjgh-2020-003573
- Kwok KO, Li KK, Chan HHH, et al. Community responses during early phase of COVID-19 epidemic, Hong Kong. Emerg Infect Dis. 2020;26:1575–1579.
- Koh WC, Alikhan MF, Koh D, et al. Containing COVID-19: implementation of early and moderately stringent social distancing measures can prevent the need for large-scale lockdowns. Ann Glob Health. 2020;86:88.
- Huang IY. Fighting against COVID-19 through government initiatives and collaborative governance: Taiwan experience. Public Adm Rev. 2020;80:665–670.
- Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: Big Data analytics, new technology, and proactive testing. JAMA. 2020;323:1341–1342.
- Bohmer MM, Buchholz U, Corman VM, et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Lancet Infect Dis. 2020;20:920–928.
- Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382:970–971.
- An der Heiden M. Schätzung der aktuellen Entwicklung der SARS-CoV-2- Epidemie in Deutschland-nowcasting. Epi Bull. 2020;17:1–18.
- European Centre for Disease Prevention and Control. Covid-19; 2020 [cited 2020 Dec 01]. Available from: https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html
- Hunter DJ. Covid-19 and the stiff upper lip - the pandemic response in the UK. N Engl J Med. 2020;382:e31.
- Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395:1225–1228.
- Stafford N. Covid-19: why Germany’s case fatality rate seems so low. BMJ. 2020;369:m1395.
- Fagiuoli S, Lorini FL, Remuzzi G. Covid-19 Bergamo Hospital crisis U. Adaptations and lessons in the Province of Bergamo. N Engl J Med. 2020;382:e71.
- Meier K, Glatz T, Guijt MC, et al. Public perspectives on protective measures during the COVID-19 pandemic in the Netherlands, Germany and Italy: a survey study. PLoS One. 2020;15:e0236917.
- Prather KA, Marr LC, Schooley RT, et al. Airborne transmission of SARS-CoV-2. Science. 2020;370:303–304.
- RKI. Aktueller Lage-/Situationsbericht des RKI zu COVID-19. 2020. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Gesamt.html
- Dullien S, Herzog-Stein A, Hohlfeld P, et al. Schneller Ausstieg oder bedachte Lockerung? Zur Zukunft von Kontaktbeschränkungen in der Covid-19-Krise. IMK Policy Brief. 2020;88:790–791.
- Linden M, Dehning J, Mohring J, et al. Überschreitung der Kontaktnachverfolgungskapazität gefährdet die Eindämmung von Covid-19. Deutsches Ärzteblatt. 2020;117.
- Beerheide R, Maibach-Nagel E. Pandemiekonzepte: differenzierte Ansätze. Deutsches Ärzteblatt. 2020;117:1728–1729.
- Bedford J, Enria D, Giesecke J, et al. Living with the COVID-19 pandemic: act now with the tools we have. Lancet. 2020. DOI:https://doi.org/10.1016/S0140-6736(20)32117-6
- Science News Staff. USA strains to act as cases set record. Science. 2020;368:17–18.
- The Lancet. COVID-19 in Latin America: a humanitarian crisis. Lancet. 2020;396:1463.
- Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395:1973–1987.
- Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584:257–261.
- Li Y, Campbell H, Kulkarni D, et al. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2020. DOI:https://doi.org/10.1016/S1473-3099(20)30785-4
- Brost M, Yang X. Virenschutz statt Datenschutz. Die Zeit. 2020;47:285–290.
- Hernandez JM. SARS-CoV-2 risk misclassification explains poor COVID-19 management. Lancet. 2020;396:1733–1734.
- Razum O, Sridhar D, Jahn A, et al. Polio: from eradication to systematic, sustained control. BMJ Glob Health. 2019;4:e001633.
- Furuse Y, Sando E, Tsuchiya N, et al. Clusters of coronavirus disease in communities, Japan, January-April 2020. Emerg Infect Dis. 2020;26. DOI:https://doi.org/10.3201/eid2609.202272
- Patel J, Sridhar D. We should learn from the Asia-Pacific responses to COVID-19. Lancet Reg Health. 2020;5. DOI:https://doi.org/10.1016/j.lanwpc.2020.100062
- Manca AR. Social cohesion. In: Michalos AC, editor. Encyclopedia of quality of life and well-being research. Dordrecht: Springer; 2014. Available from: https://link.springer.com/referenceworkentry/10.1007%2F978-94-007-0753-5_2739
- Dostal JM. Governing under pressure: German policy making during the coronavirus crisis. Polit Q. 2020;91:542–552.
- Gurdasani D, Bear L, Bogaert D, et al. The UK needs a sustainable strategy for COVID-19. Lancet. 2020;396:1800–1801.
- Forman R, Atun R, McKee M, et al. 12 lessons learned from the management of the coronavirus pandemic. Health Policy. 2020;124:577–580.
- Lal A, Erondu NA, Heymann DL, et al. Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage. Lancet. 2020;4:e306–e308.